Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Enrolling by invitation · NCT07034859 · Registry updated 2025-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cabergoline in the Management of Nonfunctioning Pituitary Adenoma | Neoplasms by Site, Pituitary Neoplasms, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland adenoma, pituitary gland disorder, supratentorial cancer | Enrolling by invitation | Phase 4 | 2025-06-24 | NCT07034859 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | 9 |